Ovarian cancer can still develop after a hysterectomy, and its symptoms are the same as in anyone else: persistent bloating, pelvic pain, feeling full quickly, and urinary changes. Whether you’re at risk depends on what type of hysterectomy you had and whether your ovaries were removed. Even if both ovaries were taken out, a closely related cancer can form in the tissue lining your abdomen.
Why Ovarian Cancer Is Still Possible After Hysterectomy
A hysterectomy removes the uterus, but the ovaries are often left in place. In a partial hysterectomy, only the uterus is removed. In a total hysterectomy, the uterus and cervix are both removed. In either case, the ovaries remain intact, which means they can still develop cancer. Only a total hysterectomy with bilateral salpingo-oophorectomy, which removes the uterus, cervix, both ovaries, and both fallopian tubes, eliminates the ovaries entirely.
Even that most comprehensive surgery doesn’t reduce the risk to zero. The cells lining the inside of your abdomen (the peritoneum) are the same type of cells that cover the surface of the ovaries. A cancer called primary peritoneal cancer can develop in this abdominal lining regardless of whether the ovaries are present. It behaves almost identically to ovarian cancer, spreads the same way, and produces the same symptoms. Doctors often can’t tell where the cancer originally started because both types spread along the internal lining of the abdomen.
Data from Kaiser Permanente found that women who had a hysterectomy without ovary removal developed ovarian cancer at a rate of about 26 per 100,000 person-years. That’s a relatively low absolute number, but it confirms the risk is real and worth monitoring.
Symptoms to Watch For
The symptoms of ovarian or peritoneal cancer after hysterectomy are the same core set seen in anyone with these cancers. The challenge is that they overlap with common, harmless complaints, especially digestive ones. The key distinction is persistence and frequency. Symptoms that show up 12 or more times per month, are new for you, and last more than a few weeks warrant attention.
The most common symptoms include:
- Bloating or a swollen abdomen that doesn’t come and go with meals or your cycle (which you may no longer have post-hysterectomy), but instead feels constant or near-constant.
- Pelvic or abdominal pain. This can feel like pressure, tenderness, or a dull ache in the lower belly or the area between your hips. After a hysterectomy, some women dismiss this as surgical-related discomfort, especially if it develops within the first year or two.
- Feeling full quickly or losing your appetite. You may sit down to eat and feel satisfied after just a few bites, even when you haven’t eaten much. This happens because fluid buildup or a growing mass puts pressure on the stomach and intestines.
- Urinary urgency or frequency. Needing to urinate more often, or feeling a sudden urgency that’s new for you, can result from pressure on the bladder.
Why These Symptoms Are Easy to Miss
People often don’t notice symptoms until the cancer has already progressed. That’s partly because the early signs, like bloating and indigestion, feel so ordinary. After a hysterectomy, there’s an additional psychological barrier: many women believe their risk of gynecological cancer is gone, so they’re less likely to flag these symptoms to a doctor or connect them to a possible cancer.
There’s no period to track irregularities in, and there’s no uterus to cause cramping, so two of the signals that sometimes prompt women to seek gynecological care are absent. The remaining symptoms, bloating, fullness, pelvic discomfort, and urinary changes, are easy to attribute to aging, diet, irritable bowel syndrome, or urinary tract issues. This is why the frequency threshold matters so much. Occasional bloating after a big meal is normal. Bloating that happens most days for several weeks straight is a different pattern.
Estrogen Therapy and Ovarian Cancer Risk
Women who have had a hysterectomy but kept their ovaries sometimes take estrogen-only hormone therapy to manage menopausal symptoms. (Without a uterus, there’s no need to add a progestin to protect against endometrial cancer.) Estrogen-only therapy is linked to a small increase in ovarian cancer risk, particularly while you’re actively taking it and the longer you use it. The overall risk remains low, and it decreases after stopping. If you’re on estrogen-only therapy and still have your ovaries, this is worth factoring into conversations about long-term monitoring.
What Gets Checked and How
If you report persistent symptoms fitting the pattern above, your doctor will typically start with a physical exam and blood work, including a protein marker that tends to be elevated in ovarian and peritoneal cancers. Imaging, usually a transvaginal or abdominal ultrasound, helps identify masses or fluid buildup. If the ovaries were previously removed, a CT scan is more likely because there’s no ovary to visualize on ultrasound, and the goal shifts to looking for peritoneal disease.
The diagnostic process can take longer for women who’ve had a hysterectomy, precisely because doctors may not immediately suspect a gynecological cancer. Being specific when describing your symptoms helps. Rather than saying “my stomach has been off,” tell your doctor how often the bloating occurs, how many weeks it’s lasted, and whether it’s accompanied by pelvic pressure or urinary changes. That level of detail can move you from a general workup to a targeted one much faster.
Who Faces the Highest Risk
Having a family history of ovarian or breast cancer raises your baseline risk regardless of surgical history. Inherited gene mutations, particularly BRCA1 and BRCA2, are the strongest known risk factors for ovarian cancer. If you carry one of these mutations and had a hysterectomy without your ovaries removed, the residual risk is significant enough that many doctors recommend a follow-up surgery to remove the ovaries and fallopian tubes.
Women who had their hysterectomy for endometriosis, fibroids, or abnormal bleeding, and kept their ovaries for hormonal benefits, make up a large portion of the post-hysterectomy population. For most of them, ovarian cancer risk is low in absolute terms. But the fact that it’s possible, and that symptoms are subtle, makes awareness the most practical tool available. There is no reliable screening test for ovarian cancer in average-risk women, so recognizing a persistent symptom pattern and acting on it early remains the best path to earlier detection.